FDA blames 'manufacturing delays' for short supply of EpiPen

The FDA said that manufacturing delays were creating intermittent supply constraints of the emergency allergy treatment in the US. There is also a shortage this week in Australia.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news